trending Market Intelligence /marketintelligence/en/news-insights/trending/2yzaq2t9yd_vntdoqyktta2 content esgSubNav
In This List

Avid Bioservices CFO resigns

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Avid Bioservices CFO resigns

Paul Lytle is voluntarily resigning as CFO of Avid Bioservices Inc.

Lytle's resignation will be effective 90 days from the date of his Feb. 23 notice.

The company is starting a search for its next CFO.

Avid Bioservices is a Tustin, Calif.-based a biopharmaceutical company that researches and develops antibodies for the treatment of cancer in the U.S.